| Followers | 83 |
| Posts | 36201 |
| Boards Moderated | 0 |
| Alias Born | 03/09/2010 |
Wednesday, November 09, 2022 1:27:13 PM
like this:
The results contain some surprises. Daniel Himmelstein, a computational-biology graduate student at the University of California, San Francisco, analysed all the papers indexed in the PubMed database that had listed submission and acceptance dates. His study, done for Nature, found no evidence for lengthening delays2: the median review time — the time between submission and acceptance of a paper — has hovered at around 100 days for more than 30 years (see 'Paper wait'). But the analysis comes with major caveats. Not all journals — including some high-profile ones — deposit such time-stamp data in PubMed, and some journals show when a paper was resubmitted, rather than submitted for the first time. “Resetting the clock is an especially pernicious issue,” Himmelstein says, and it means that the analysis might be underestimating publication delays.
hmmmm 100 days is less than 2.5 years, I think we all agree on that LOL
The results contain some surprises. Daniel Himmelstein, a computational-biology graduate student at the University of California, San Francisco, analysed all the papers indexed in the PubMed database that had listed submission and acceptance dates. His study, done for Nature, found no evidence for lengthening delays2: the median review time — the time between submission and acceptance of a paper — has hovered at around 100 days for more than 30 years (see 'Paper wait'). But the analysis comes with major caveats. Not all journals — including some high-profile ones — deposit such time-stamp data in PubMed, and some journals show when a paper was resubmitted, rather than submitted for the first time. “Resetting the clock is an especially pernicious issue,” Himmelstein says, and it means that the analysis might be underestimating publication delays.
hmmmm 100 days is less than 2.5 years, I think we all agree on that LOL
THEY HATE ME CAUSE THEY AINT ME
NAILED IT ON EVERY STOCK
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
